Target intelligence / Profile preview

Glutamate-rich protein 2 (ERICH2)

Target
ERICH2
Molecular classification
Other
01

Overview

Glutamate-rich protein 2 (ERICH2) is a protein encoded by the ERICH2 gene, expressed almost exclusively in the testes in both humans and mice, with minor expression in a few other tissues such as the choroid plexus in developing fetuses and weakly in adult lung and female tissues. The protein is found in the nucleoli fibrillar center and vesicles within testicular cells. Structurally, it contains motifs possibly related to phosphorylation and amidation, and a domain (PHA03247) of uncertain function. Its conserved interactions are mainly with histone H2A family members—including H2AFY, which is involved in X chromosome inactivation—suggesting a role in chromatin dynamics and possibly histone modification. It also interacts with proteins like SDCB1 (involved in vesicle trafficking and cancer cell regulation) and IWS1 (a transcription factor contributing to histone modification and RNA splicing). Despite being highly expressed in the testis, knockout studies in mice reveal ERICH2 is not required for male fertility or reproductive organ development, indicating its function is nonessential in vivo for fertility. There is currently no evidence supporting its role as a therapeutic target, nor are there established drugs, mechanisms of action, or biomarker roles for ERICH2.

Other names
glutamate-rich 2ERICH2
02

Biological functions

Potential involvement in histone modificationPossible role in vesicle traffickingAssociation with chromatin structure (via histone interactions)
03

Disease associations

Other (no direct association with major diseases established; interaction with SDCB1 may relate to cancer cell proliferation, but ERICH2 itself is not established as a disease gene)
04

Safety considerations

No known safety concerns; CRISPR/Cas9 knockout models in mice show loss of ERICH2 does not affect reproductive function or overall health

Beyond the preview

Go deeper on Glutamate-rich protein 2 (ERICH2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate-rich protein 2 (ERICH2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call